| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2985 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2013-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f72877fb6dba54b1ffdb14447e540b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d269a1ff6933442f6c03fc95e7e66de0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285517f670e077bdc3ce8c26c34bc881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_081427ec119a6863f686ffa5b6367668 |
| publicationDate |
2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9056045-B2 |
| titleOfInvention |
Intraocular biodegradable microspheres |
| abstract |
Biocompatible intraocular microspheres can include an active agent and a biodegradable polymer that is effective to facilitate release of the active agent into the vitreous of an eye for an extended period of time. The therapeutic agent of the microsphere can be associated with a biodegradable polymer matrix and can be made by crystallizing the active agent in the matrix. the resulting biodegradable microspheres can be placed into an eye to treat or reduce the occurrence of one or more ocular conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10059621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11384009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11395853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10647962-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857259-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751367-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11274059-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11198638-B2 |
| priorityDate |
2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |